Sight Sciences, Inc. (SGHT) Balance Sheet

NASDAQ: SGHTAssets, liabilities, debt and equity over 8 years.

SGHT balance sheet, 2025

December 31, 2025 · U.S. dollars

$115.3M assets = $51.4M liabilities + $63.9M equity

What it owns$115.3MCash & ST investments: $92.0M (79.8%)Cash & ST investments$92.0M · 80%Receivables: $9.7M (8.5%)Receivables $9.7MInventory: $7.8M (6.7%)Inventory $7.8MOther current: $3.3M (2.8%)PP&E: $2.0M (1.8%)Other non-current: $518,000 (0.4%)=How it is financed$115.3MCurrent liabilities: $11.0M (9.6%)Current liabilities $11.0MLong-term debt: $40.3M (35.0%)Long-term debt$40.3M · 35%Other LT liabilities: $31,000 (0.0%)Shareholders’ equity: $63.9M (55.5%)Shareholders’ equity$63.9M · 55%

Both columns are drawn to the same scale: what SGHT owns equals what it owes plus shareholders’ equity. Hover a block for its value.

SGHT financial health

Debt / equity0.64
Moderate leverage · $0.64 of debt for each $1 of equity
Equity / assets55.5%
Equity-funded · of assets funded by shareholders
Cash / debt225.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

SGHT balance sheet trends, 2018–2025

Sight Sciences, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$8.1M2018$115.3M2025+46.2%/yr
Total liabilities$37.1M2018$51.4M2025+4.8%/yr
Shareholders’ equity−$29.0M2018$63.9M2025—
Cash & short-term investments$4.2M2018$92.0M2025+55.2%/yr
Total debt$34.2M2018$40.8M2025+2.6%/yr
Net cash (debt)−$29.9M2018$51.2M2025+$81.1M
Working capital$4.3M2018$101.7M2025+$97.4M
Book value per share−$0.902018$1.232025—
Debt / equity0.1420210.642025+0.49
Shares outstanding32.2M201852.1M2025+7.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

SGHT assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

SGHT liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

SGHT debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

SGHT balance sheet

Sight Sciences, Inc. annual balance sheet
20252024202320222021202020192018
Assets
Cash & short-term investments$92.0M$120.4M$138.1M$185.0M$260.7M$61.5M$21.2M$4.2M
Cash & equivalents$92.0M$120.4M$138.1M$185.0M$260.7M$61.5M$21.2M$4.2M
Receivables$9.7M$10.8M$14.3M$15.1M$8.7M$5.4M$4.1M$1.8M
Inventory$7.8M$6.3M$7.8M$6.1M$3.5M$2.6M$2.2M$486,000
Other current assets$3.3M$2.3M$2.6M$3.4M$4.2M$1.2M$426,000$621,000
Total current assets$112.7M$139.8M$162.9M$209.7M$277.0M$70.6M$28.0M$7.2M
Property, plant & equipment (net)$2.0M$2.5M$3.1M$3.2M$2.9M$1.8M$2.6M$868,000
Goodwill & intangible assets$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0
Other non-current assets$518,000$550,000$682,000$211,000$202,000$386,000$168,000$62,000
Total assets$115.3M$142.8M$166.7M$213.1M$280.2M$72.8M$30.7M$8.1M
Liabilities
Accounts payable$1.3M$1.7M$1.7M$2.7M$3.4M$2.2M$2.3M$1.9M
Short-term debt$475,000$533,000$2.8M$1.0M$510,000$395,000$557,000—
Total current liabilities$11.0M$15.5M$12.3M$17.8M$13.5M$9.3M$7.3M$2.9M
Long-term debt$40.3M$39.4M$31.7M$33.3M$32.7M$32.0M$12.9M$0
Lease obligations$475,000$1.0M$1.5M$1.7M$1.6M$529,000$1.1M$0
Other long-term liabilities$31,000$492,000$2.5M$1.9M$1.9M$120.4M$65.2M$34.2M
Total liabilities$51.4M$55.3M$46.4M$53.0M$48.1M$161.7M$85.4M$37.1M
Shareholders' equity
Common stock & paid-in capital$54,000$51,000$49,000$48,000$48,000$9,000$9,000$9,000
Retained earnings (deficit)−$384.7M−$346.3M−$294.8M−$239.2M−$153.0M−$90.0M−$55.3M−$29.5M
Accumulated other comprehensive income———$0−$280.2M−$119.4M−$64.5M−$34.2M
Total shareholders' equity$63.9M$87.5M$120.2M$160.1M$232.1M−$88.8M−$54.7M−$29.0M
Key figures
Total debt$40.8M$40.4M$35.4M$35.0M$33.2M$32.5M$13.9M$34.2M
Net cash (debt)$51.2M$80.0M$102.7M$150.0M$227.5M$29.0M$7.3M−$29.9M
Working capital$101.7M$124.3M$150.6M$191.9M$263.5M$61.3M$20.7M$4.3M
Tangible book value$63.9M$87.5M$120.2M$160.1M$232.1M−$88.8M−$54.7M−$29.0M
Book value per share$1.23$1.75$2.47$3.35$4.89−$1.90−$1.63−$0.90
Shares outstanding52.1M50.1M48.6M47.8M47.5M46.8M33.6M32.2M
Current ratio10.229.0413.2911.7720.527.583.822.47
Quick ratio9.228.4812.4411.2319.957.183.452.09
Debt / equity0.640.460.290.220.14———
Equity / assets55.5%61.3%72.1%75.1%82.8%−122.0%−177.9%−357.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 4, 2026); data from EODHD.

SGHT financial position

At the end of fiscal 2025 (December 31, 2025), Sight Sciences had total assets of $115.3 million (down 19.3% from a year earlier), total liabilities of $51.4 million and shareholders' equity of $63.9 million. It held $92.0 million in cash and short-term investments against $40.8 million of debt, a net cash position of $51.2 million. Its current ratio was 10.22. In the latest quarter (ended June 30, 2026) total assets were $104.9 million and equity $52.9 million.

Related: SGHT income statement, SGHT cash flow statement, SGHT key metrics. See the SGHT stock overview for the latest quote and news.

SGHT balance sheet FAQ

What are Sight Sciences's total assets?

Sight Sciences reported total assets of $115.3 million at the end of fiscal 2025 (December 31, 2025), compared with $142.8 million a year earlier.

How much debt does Sight Sciences have?

Sight Sciences had $40.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.64.

How much cash does Sight Sciences have?

Sight Sciences held $92.0 million in cash and short-term investments at the end of fiscal 2025; with $40.8 million of debt that is net cash of $51.2 million.

What is Sight Sciences's book value?

Sight Sciences's shareholders' equity (book value) was $63.9 million at the end of fiscal 2025, or $1.23 per share.

What is Sight Sciences's current ratio?

Sight Sciences had current assets of $112.7 million and current liabilities of $11.0 million, a current ratio of 10.22 (it can cover its short-term obligations).

Medical Devices: balance sheet